(mycoses fungoides, Sezary syndrome, and cutaneous T-cell lymphoma)

Bunn PA, Lamberg SI.

Report of the committee on staging and classification of cutaneous T-cell lymphomas.
Cancer Treat Rep. 1979;63:275-8.
Description: Original staging system for mycosis fungoides/sezary syndromes.
PubMed citation number: 445521

Sausville EA, et al.

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups.
Ann Intern Med. 1988;109:372-82.
Description: Simplified staging system for mycosis fungoides/Sezary syndrome.
PubMed citation number: 3408055

Kaye FJ, Bunn PA Jr, Steinber SM, et al.

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
N Engl J Med. 1989;321:1784-90.
Description: Randomized controlled trial of combined therapy (electron beam + chemo) versus topical treatment. Reports high toxicity but no improvements in disease-free or overall survival with combined modality therapy.
PubMed citation number: 2594037

Bunn PA Jr, Hoffman SJ, Norris D, et al

.

Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome).
Ann Intern Med. 1994;121:592-602.
Description: Systematic review of the use of systemic therapy for mycosis fungoides and Sezary syndrome. Concludes that systemic therapy is active, but not curative.
PubMed citation number: 8085692

Olsen EA, Bunn PA Jr.

Interferon in the treatment of cutaneous T-cell lymphoma.
Hematol Oncol Clin North Am. 1995;9:1089-107.
Description: Review of the use of interferon in the treatment of mycosis fungoides and Sezary syndrome.
PubMed citation number: 8522486

Willemze R, et al.

EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
Blood. 1997;90:354-71.
Description: A classification system for cutaneous lymphoma which attempts to capture the distinct clinical and pathologic features of the cutaneous lymphomas.
PubMed citation number: 9207472

Zackheim HS, Kashani-Sabet M, Amin S.

Topical corticosteroids for mycosis fungoides. Experience in 79 patients.
Arch Dermatol. 1998;134:949-54.
Description: Largest reported case series of clinical experience with steroids for MF.
PubMed citation number: 9722724

Weinstock MA, Gardstein B.

Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality. Am J Public Health. 1999;89:1240-1244.
Description: Epidemiologic data on incidence and prognosis of MF.
PubMed citation number: 10432915

Bisaccia E, Gozalez J, Palangio M, et al.

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
J Am Acad Dermatol. 2000;43:263-71.
Description: Retrospective case series of photochemotherapy for cutaneous T-cell lymphoma. Reports complete response rate of 14% and partial response rate of 41%.
PubMed citation number: 10906649

Jones GW, Kacinski BM, Wilson LD, et al.

Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group.
J Am Acad Dermatol. 2002;47:364-70.
Description: Consensus statement from the EORTC Cutaneous Lymphoma Project Group on the role of total skin electron radiation in the treatment of mycosis fungoides.
PubMed citation number: 12196745

Connors JM, His ED, Foss FM.

Lymphoma of the Skin.
Hematology (Am Soc Hematol Educ Program). 2002:263-82.
Description: Succinct review.
PubMed citation number: 12446427

Baron ED, Stevens SR.

Phototherapy for cutaneous T-cell lymphoma.
Dermatol Ther. 2003;16:303-10.
Description: A review of the different types of phototherapy available (broadband UVB, PUVA etc.), and their role in the management of cutaneous T-cell lymphoma

Return to Table of Contents